INS and metabolic disease: As Asians may suffer disproportionately from metabolic diseases due to lower insulin sensitivity (which triggers weight gain), the use of such drugs after testing in diverse Asian populations may relieve both metabolic and musculoskeletal stress due to weight loading on the hips and legs [4,156].